Proudly Canadian
Independent batch testing Β· Clear documentation
All prices in CAD

CURRENT BATCH: BW-RETA-10-040626
Size
GLP3 is a triple hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors. Designed for the treatment of obesity, type 2 diabetes, and metabolic disorders. It acts by simultaneously mimicking three gut hormones to regulate appetite, metabolism, and fat breakdown.
For laboratory research use only.
The YHS Verification Standardβ’
Independently verified for quality and purity
High-performance liquid chromatography verified
Tested for bacterial endotoxins
Batch-specific documentation available
CURRENT BATCH: BW-RETA-10-040626
(LY3437943) is an investigational triple agonist targeting GIP, GLP-1, and glucagon receptors, widely studied for its effects on energy balance, body-weight regulation, and metabolic signaling.
Store as directed to help preserve product quality and research integrity.
HPLC testing confirms peptide purity by separating and measuring individual compounds within each sample.
Freeze-dried for stability. Reconstitution is required before use.
See how we compare to other suppliers
| MOST SUPPLIERS | OUR PEPTIDES | |
|---|---|---|
| Canadian GMP Manufactured | β | β |
| Canadian Raw Ingredients (API's) | β | β |
| Canadian Certified Lab Testing | β | β |
| Accessible Original Lab Results | β | β |
| Third-Party Purity Testing | β | β |
| Payment Methods | Bit-Coin & E-Transfer | Major Credit Cards & E-Transfer |
| Live Support | None | Canadian Phone & Email Support |
| Shipping speed | 7-14 Days | 1-3 Days |